PureTech Health plc (LON: PRTC)
London
· Delayed Price · Currency is GBP · Price in GBX171.20
+9.20 (5.68%)
Nov 22, 2024, 4:35 PM BST
PureTech Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -82.47 | -65.7 | -50.35 | -60.56 | 5.99 | 421.14 | Upgrade
|
| Depreciation & Amortization | 3.69 | 4.93 | 8.89 | 7.29 | 6.65 | 6.67 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.23 | -61.47 | -27.11 | 0.05 | 0.07 | -264.27 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.24 | 1.26 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -73.9 | -77.68 | 41.53 | -158.39 | -177.7 | -364.78 | Upgrade
|
| Loss (Gain) on Equity Investments | 4.09 | 6.06 | 27.75 | 73.7 | 34.12 | -30.79 | Upgrade
|
| Stock-Based Compensation | 7.81 | 4.42 | 14.7 | 13.95 | 10.72 | 14.47 | Upgrade
|
| Other Operating Activities | 21.5 | 64.75 | -210.12 | -35.18 | -3.14 | 104.38 | Upgrade
|
| Change in Accounts Receivable | 0.83 | 9.75 | -7.73 | -0.62 | -0.53 | 0.75 | Upgrade
|
| Change in Accounts Payable | -3.72 | 3.84 | 22.03 | 8.34 | 0.61 | 11.17 | Upgrade
|
| Change in Unearned Revenue | - | -0.28 | 2.12 | -1.41 | -5.22 | 0.19 | Upgrade
|
| Change in Other Net Operating Assets | 1.37 | 4.21 | -0.5 | -5.45 | -3.38 | 2.93 | Upgrade
|
| Operating Cash Flow | -120.8 | -105.92 | -178.79 | -158.27 | -131.83 | -98.16 | Upgrade
|
| Capital Expenditures | - | -0.07 | -2.18 | -5.57 | -5.17 | -12.14 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.46 | 0.87 | - | 0.03 | - | - | Upgrade
|
| Divestitures | - | -13.78 | -0.48 | - | - | -16.04 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.18 | -0.18 | - | -0.09 | -0.25 | -0.4 | Upgrade
|
| Investment in Securities | 132.83 | 99.01 | -104.98 | 217.63 | 369.55 | 98.52 | Upgrade
|
| Other Investing Activities | -1.5 | -16.85 | 0.42 | -14.62 | 0.35 | -6.29 | Upgrade
|
| Investing Cash Flow | 131.62 | 68.99 | -107.22 | 197.38 | 364.48 | 63.66 | Upgrade
|
| Short-Term Debt Issued | - | - | 0.39 | 2.22 | 25 | 1.61 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 14.79 | - | Upgrade
|
| Total Debt Issued | - | - | 0.39 | 2.22 | 39.79 | 1.61 | Upgrade
|
| Long-Term Debt Repaid | - | -3.34 | -4.03 | -3.38 | -2.91 | -1.86 | Upgrade
|
| Net Debt Issued (Repaid) | -3.22 | -3.34 | -3.63 | -1.16 | 36.88 | -0.25 | Upgrade
|
| Issuance of Common Stock | 1.09 | 1.15 | 0.33 | 0.35 | 1.04 | 0.5 | Upgrade
|
| Repurchase of Common Stock | -118.82 | -19.65 | -26.49 | -13.33 | - | -1.28 | Upgrade
|
| Other Financing Activities | 68.1 | 99.98 | -0.04 | 36.87 | 0.95 | 50.94 | Upgrade
|
| Financing Cash Flow | -52.86 | 78.14 | -29.83 | 22.73 | 38.87 | 49.91 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.1 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | - | Upgrade
|
| Net Cash Flow | -42.04 | 41.22 | -315.84 | 61.83 | 271.52 | 15.31 | Upgrade
|
| Free Cash Flow | -120.8 | -105.99 | -180.97 | -163.85 | -137 | -110.29 | Upgrade
|
| Free Cash Flow Margin | -25811.54% | -3182.79% | -1158.71% | -942.29% | -1164.15% | -1124.65% | Upgrade
|
| Free Cash Flow Per Share | -0.44 | -0.38 | -0.64 | -0.57 | -0.47 | -0.38 | Upgrade
|
| Cash Interest Paid | 1.25 | 1.7 | 3.37 | 3.38 | 2.65 | 2.5 | Upgrade
|
| Cash Income Tax Paid | 15.21 | 0.15 | 20.7 | 27.77 | 20.74 | - | Upgrade
|
| Levered Free Cash Flow | -1.52 | -114.8 | -236.95 | -41.45 | -52.29 | -195.02 | Upgrade
|
| Unlevered Free Cash Flow | 11.01 | -106.37 | -234.48 | -38.51 | -50.45 | -192.46 | Upgrade
|
| Change in Net Working Capital | -84.97 | 24.1 | 132.27 | -39.85 | -12.32 | 116.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.